Background/Aim: Human mesenchymal stem cells (hMSC) represent a versatile cell population, able to modulate the tumor microenvironment. Our aim was to recreate an open scene for the in vivo interaction between hMSC and the MCF-7 breast cancer cells , in order to enlighten the intimate involvement of hMSC in tumor vasculogenesis and angiogenesis. Materials and Methods: hMSC and MCF-7 were seeded onto the chick embryo chorioallantoic membrane (CAM) and incubated for 7 days. Consecutively, the morphology and the immunohistochemical profile of CAM were assessed. Results: Following this complex interaction, MCF-7 acquired a more aggressive phenotype, hMSC switched to a vascular precursor phenotype, while CAM underwent a major reset to an earlier stage, with hotspots of angiogenesis, vasculogenesis and hematopoiesis.
Conclusion: The hallmark of this study was the establishment of a veritable in vivo experimental model of MSC involvement in tumor vasculogenesis and angiogenesis, allowing further analysis in the field.As tumor vasculature has been thought to emerge by expansion of the host vasculature through postnatal sprouting of endothelial cells (angiogenesis), it was proposed that inhibiting angiogenesis would stop tumor growth, but it turned out that tumor vessels form through vasculogenesis, rather than through angiogenesis, the process involving circulating bone marrow-derived endothelial precursors rather than mature endothelial cells (1).Lately, mesenchymal stem cells (MSC) have generated substantial interest in the medical areas of transplant, regenerative medicine and cancer treatment because of their multi-potency and multi-functionality. MSC are a heterogeneous subset of stromal cells present in several tissues including bone marrow, bone, adipose tissue, skin, kidney, umbilical cord and placenta (2).MSC are localized in the vascular niche in bone marrow, but also found as MSC-like cells around adult vessels and there is substantial evidence that they play a pivotal role in regulating blood vessel formation and function through multiple mechanisms such as vasculogenesis, arteriogenesis and angiogenesis (3).While MSC differentiation towards vascular cell lineages and their incorporation into a growing vessel wall is rather ill-defined, their important contribution to promoting postnatal vascularization during ischemic myocardial tissue regeneration and tumor vasculogenesis is becoming increasingly recognized (4). It seems that hypoxia serves to enhance the differentiation of MSC towards the endothelial phenotype. Additionally, a revised understanding of MSCderived neovascularization contextualizes their behavior and utility as a hybrid endothelial-stromal cell type, with mixed characteristics of both populations (5).Currently, the role of MSC in carcinogenesis is a matter of controversy. It has been reported that they favor tumor growth due to the immunosuppression they induce. Also, MSC could enhance tumor metastatic potential since they induce epithelial-to-mesenchymal transition (EMT). Other results prove...